These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 7560483)

  • 21. Hemostatic-endothelial interactions: a potential anticoagulant role of the endothelium in the pulmonary circulation during cardiac surgery.
    Cardigan RA; Mackie IJ; Machin SJ
    J Cardiothorac Vasc Anesth; 1997 May; 11(3):329-36. PubMed ID: 9161902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
    Krueger K; Schmutz A; Zieger B; Kalbhenn J
    Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of regional citrate anti-coagulation on the coagulation system in critically ill patients receiving continuous renal replacement therapy for acute kidney injury - an observational cohort study.
    Fisher R; Lei K; Mitchell MJ; Moore GW; Dickie H; Tovey L; Crichton S; Ostermann M
    BMC Nephrol; 2017 Oct; 18(1):304. PubMed ID: 28969597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
    Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
    J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arterial-venous perfusion without anticoagulation: the impeller centrifugal pump.
    Vertrees RA; Yu Y; Wacker C; Cernaianu AC; DelRossi AJ
    J Extra Corpor Technol; 1991; 22(4):160-3. PubMed ID: 10149016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulation for continuous renal replacement therapy.
    Tolwani AJ; Wille KM
    Semin Dial; 2009; 22(2):141-5. PubMed ID: 19426417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Arvin anticoagulant for prolonged extracorporeal membrane oxygenation (author's transl)].
    White JJ; Bell W; Matthews P; Büky B
    Anaesthesist; 1976 Nov; 25(11):526-8. PubMed ID: 1008240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Citrate anticoagulation for extracorporeal circuits: effects on whole blood coagulation activation and clot formation.
    Calatzis A; Toepfer M; Schramm W; Spannagl M; Schiffl H
    Nephron; 2001 Oct; 89(2):233-6. PubMed ID: 11549910
    [No Abstract]   [Full Text] [Related]  

  • 29. Extracorporeal membrane oxygenation in the adult: a review of anticoagulation monitoring and transfusion.
    Esper SA; Levy JH; Waters JH; Welsby IJ
    Anesth Analg; 2014 Apr; 118(4):731-43. PubMed ID: 24651227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Citrate: an additional resource for anticoagulation in continuous replacement therapy].
    Pozzato M
    G Ital Nefrol; 2012; 29(1):20-6. PubMed ID: 22388902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anticoagulation of the extracorporeal circuit in chronic hemodialysis].
    Ryckelynck JP; Chouraqui D; Lobbedez T
    Nephrologie; 1998; 19(4):223-5. PubMed ID: 9675763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ex vivo testing of heparin-coated extracorporeal circuits: bovine experiments.
    Weerwind PW; van der Veen FH; Lindhout T; de Jong DS; Cahalan PT
    Int J Artif Organs; 1998 May; 21(5):291-8. PubMed ID: 9684912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term extracorporeal circulation management: the role of low- and high-range heparin ACT tests.
    Herbst D; Najm HK; Jha KN
    J Extra Corpor Technol; 2008 Dec; 40(4):271-4. PubMed ID: 19192757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The approach to anticoagulation in patients treated with extracorporeal therapy in the intensive care unit.
    Ward DM
    Adv Ren Replace Ther; 1997 Apr; 4(2):160-73. PubMed ID: 9113232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulation strategies in extracorporeal circulatory devices in adult populations.
    Kato C; Oakes M; Kim M; Desai A; Olson SR; Raghunathan V; Shatzel JJ
    Eur J Haematol; 2021 Jan; 106(1):19-31. PubMed ID: 32946632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ; Joist JH
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
    J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Essentials of anticoagulation in hemodialysis.
    Fischer KG
    Hemodial Int; 2007 Apr; 11(2):178-89. PubMed ID: 17403168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The safety and efficacy of a new anticoagulation strategy using selective in-circuit blood cooling during haemofiltration--an experimental study.
    Krouzecky A; Chvojka J; Sykora R; Radej J; Karvunidis T; Novak I; Hanzlikova J; Bultasova L; Ruzicka J; Petrankova Z; Matejovic M
    Nephrol Dial Transplant; 2011 May; 26(5):1622-7. PubMed ID: 20935015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring anticoagulation and hemostasis in cardiac surgery.
    Shore-Lesserson L
    Anesthesiol Clin North Am; 2003 Sep; 21(3):511-26. PubMed ID: 14562563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.